Indocyanine Green is a dye used to help doctors see blood flow and take better images during eye exams and certain surgical procedures. It's injected into the bloodstream and shows up brightly under special infrared light, allowing doctors to visualize blood vessels and tissues.[2] IC-Green is currently approved and in use across 51 indications[4].[1]
IC-Green is one of 629 small molecule programs targeting Lung Cancer. It is currently in Approved.
Indications
Total Trials
Active Trials
Competitors
FDA Applications
NDA/BLA/ANDA regulatory filings
Patents
Pipeline
Competition
744 competitors in Breast Cancer
IC-Green
Methylthioninium Chloride
Tricor
Acupan
Duragesic
Rilvegostomig
Paracetamol
Ablavar
Gadolinium-Chelate
4SCAR T Cells
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Gastric Cancer
NCT04611997
Intraoperative
NCT04752137
Stage I Uterine Corpus Carcinoma or Carcinosarcoma AJCC V8
NCT05646316
Indocyanine Green
NCT04842162
Giant Cell Tumor
NCT07315828
Lung Cancer
NCT02570815
Clinical
Regulatory
Jan 1, 1982
IC-GREEN
NDA NDA011525
Nov 21, 2018
SPY AGENT GREEN KIT
NDA NDA211580
Jul 9, 2026
ZYOGREEN
NDA NDA218579
Sources
Details